GO

Latest:

  • PRODUCT UPDATE - ACCU-CHECK MOBILE GLUCOSE TESTS

     

    IMPORTANT - THIS NOTICE ONLY APPLIES TO PEOPLE CURRENTLY USING ACCU-CHECK MOBILE GLUCOSE TESTS AND UNDERGOING CEFTRIAXONE THERAPY.

    CEFTRIAXONE THERAPY GENERALLY OCCURS IN A HOSPITAL OR OTHER MEDICAL ENVIRONMENT.

     

    Roche Diabetes Care has informed the Therapeutic Goods Administration that patients using Accu-Check Mobile Glucose tests may receive incorrect lower blood glucose levels if they are currently undergoing ceftriaxone therapy.

     

    Ceftriaxone is an antibiotic used to treat a variety of infections including respiratory infections or lower urinary tract infections. It is only administered intravenously (injections via veins) or intramuscularly (injections via muscles).

     

    If this applies to you Roche Diabetes Care will make an alternative blood glucose monitoring system available to you for free.

     

    If you are currently using ceftriaxone, or are unsure about the medicine you are receiving intravenously or intramuscularly, you should talk to your doctor or nurse.

     

    If you have further questions please contact the Accu-Check enquiry line on 1800 251 816.

     

  • Could more accurate BGL readings be on the way?

     

    A mathematical model, created by Penn State researchers, can predict with more than 90 per cent accuracy the blood glucose levels of individuals with type 1 diabetes up to 30 minutes in advance.

     

    Many people with type 1 diabetes use continuous glucose monitors, which examine the fluid underneath the skin.

     

    Distinguished Professor of Human Development and Family Studies and of Psychology Peter Molenaar said glucose levels under the skin trail blood glucose levels from anywhere between 8 and 15 minutes ...

     

    Read More 

  • On our Facebook page...

    26 March New research

     

    Find Us on Facebook_144

  • Genes could be genius for type 2 diabetes

     

    Could a drug mimicking gene mutations be the key to keeping type 2 diabetes at bay?

     

    Scientists at a Swedish university's diabetes center think they could be onto something after they discovered gene mutations that reduce a person's risk of developing type 2 diabetes, regardless of age or weight.

     

    The researchers believe a drug that mimics the mutations may be able to slow down or stop the conditionin its tracks.

     

    They studied the genomes of older people, who were overweight and who were at high risk of type 2 diabetes but had normal blood glucose levels, honing in on the gene which is known to impact on a person's likelihood of developing type 2 diabetes.

     

    Read More ...

     

  • On our Facebook page ...

    FB_Capture_Redwine_drinkers_Type 2_04032014 

    Find Us on Facebook_144

  • Could Alzheimer's disease actually be 'type 3' diabetes?

     

    That's the new theory Australian researchers are trying to test. 

     

    Researchers are designing new drugs targeting the brain's resistance to insulin in the hope that it could play a leading part in new treatments for conditions like dementia and all types of diabetes. 

     

    Associate Professor Mike Lawrence, with the Walter and Eliza Institute, is studying the way the brain works to regulate insulin. 

     

    "We've got a discovery here that actually has possibilities for utilisation in three major diseases. We've now got the tools and knowledge to bring together all these threads," Associate Professor Lawrence said. 

     

  • Diabetes Queensland is encouraging women to take a type 2 diabetes risk assessment to reduce their risk of complications like having a stroke.

     

    This follows a University of Queensland review of more than 60 international studies that show women with type 2 diabetes have a 27 per cent higher risk of having a stroke than men with diabetes.

     

    Professor Rachel Huxley, who conducted the research in collaboration with the UK's University of Cambridge and Australia's George Institute for Global Health, said the study was the first to reveal a significant difference in the risk of stroke between men and women.

     

    "Research has shown that diabetes confers a greater risk of having a heart attack in women than men, and now we have shown that this gender difference also extends to stroke," Professor Huxley said.

     

    "Data was pooled from three-quarters of a million people, including more than 12,000 individuals who had suffered strokes, both fatal and non-fatal.

     

    "Our analysis of the data showed, in comparison to men with diabetes, women with the condition had a 27 per cent higher relative risk of stroke even after taking into account other risk factors such as age and blood pressure."

  • The flu is serious - particularly for people with all types of diabetes - and this is why Diabetes Queensland is encouraging people to make their annual flu shot a priority.

     

    Research has shown people with diabetes are six per cent more likely to be hospitalised with the flu than people without diabetes. So don't wait, make an appointment with your GP today.

     

    This year Queensland Health has already received more than 900 flu notifications and
    the flu season has just begun.

     

    "The flu, just like any other infection, interferes with your blood glucose levels," Sharon said.

     

    "Generally this means making them high which means it can take you longer to recover from the flu as well as putting you at a higher risk of developing complications of the flu." 

    See our fact sheets for sick days with type 1 and sick days with type 2 diabetes.

Diabetes. Who cares? We do. NDSS.